ArticleJACC. Case reports2025
Septal Preparation for TAVR Using Radiofrequency Catheters in Patients With LVOT Obstruction: 1-Year Follow-Up.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delayed Presentation of Suicide LV: Post-AVR LVOT Obstruction Cured by Alcohol Septal Ablation.Acta Cardiologica Sinica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricular outflow tract (LVOT) obstruction is frequent in hypertrophic cardiomyopathy. Septal radiofrequency ablation for treatment of LVOT obstruction, which is endocardial radiofrequency ablation of septal hypertrophy (ERASH), was previously performed in patients refractory to medical treatment with catheters used for cardiac arrhythmia ablation. Obstruction of the LVOT during transcatheter aortic valve replacement (TAVR) procedures may lead to suicide ventricle, the dire event of a sudden increase in the intraventricular gradient after valve obstruction alleviation. We present a 2-step procedure for septal preparation before TAVR in a series of 4 cases. All patients underwent ERASH before TAVR, which successfully reduced the LVOT gradient before implant (the longest waiting interval between procedures was 3 months and the shortest was 15 days). No patient underwent pacemaker or implantable cardioverter-defibrillator implant. To the best of our knowledge, this is the longest series of septal ablation before TAVR in patients who also presented with intraventricular LVOT obstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.